GlucoTrack replaces outgoing CFO Jolie Kahn with James S. Cardwell

Glucotrack, Inc.

Jolie Kahn resigned as CFO effective Oct 6, 2023, to pursue other interests; no disagreement with the company.
James S. Cardwell appointed CFO effective Oct 11, 2023, via a consulting agreement at $1,500/month minimum.
Cardwell is 63, with over 16 years of CFO/COO experience, including interim roles at several public companies.
Consulting agreement term is one year; part-time, non-employee; either party may terminate with 30 days' notice.
Company must obtain D&O insurance for Cardwell within 30 days of appointment.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jolie Kahn

Chief Financial Officer

GCTK · Glucotrack, Inc.

Effective: 2023-10-06
Successor: James S. Cardwell
Filed: October 12, 2023, 7:59 PM ET

Effective as of October 6, 2023, Jolie Kahn resigned as Chief Financial Officer of GlucoTrack, Inc. (the “Company”) to pursue other career interests.

Appointed

James S Cardwell

Chief Financial Officer

GCTK · Glucotrack, Inc.

Effective: 2023-10-11
Filed: October 12, 2023, 7:59 PM ET

On October 11, 2023, the Company appointed James S Cardwell, 63, as Chief Financial Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jolie Kahn resigned as Chief Financial Officer at Glucotrack, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Effective as of October 6, 2023, Jolie Kahn resigned as Chief Financial Officer of GlucoTrack, Inc. (the “Company”) to pursue other career interests.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

James S Cardwell was appointed as Chief Financial Officer at Glucotrack, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On October 11, 2023, the Company appointed James S Cardwell, 63, as Chief Financial Officer of the Company, effective immediately.

View on SEC.gov

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-037074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.